Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.4 USD | -1.57% | -14.89% | -33.53% |
Apr. 15 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
Mar. 22 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.53% | 110M | |
-3.22% | 187B | |
-2.40% | 108B | |
-4.08% | 67.71B | |
+9.59% | 53.07B | |
+15.78% | 47.36B | |
+6.01% | 39.73B | |
+10.02% | 28.56B | |
+1.35% | 26.55B | |
+15.97% | 25.13B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio's Q2 Loss Widens, Revenue Rises; Adjusts FY 2022 Revenue Estimate